To study the efficacy of Dhatri Lauh on Peptic ulcer

An Etiopathological Study of Annadrava Shoola and Parinama Shoola wsr to Peptic Ulcer and its Therapeutic Study (Upshayatamak Parikshana) with Dhatri Lauh

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028032

Enrollment

Registered

2020-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: Dhatri Lauh: Minimum 40 patients with sign and symptoms of Annadrava Shoola and Parinama Shoola will be given 500mg BD Dhatri Lauh for 30 days Control Intervention1: nill: nill

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptom of Annadrava Shoola and Parinama Shoola Patients with sign and symptom of Peptic ulcer

Exclusion criteria

Exclusion criteria: Age >70 years. Age Patients with recurrent episodes of severe pain restricting the patients from daily routine work. Associated complications of peptic ulcer. Immuno-compromised patients like Tuberculosis, HIV etc. Patients with other complicated disorders like liver cirrhosis, Zolinger-Ellison syndrome.

Design outcomes

Primary

Measure	Time frame
Relief in Sign and Symptom of Annadrava Shoola and Parinama ShoolaTimepoint: 30 days	—

Secondary

Measure	Time frame
Improve Quality of life of Patients suffering from Annadrava Shoola and Parinama ShoolaTimepoint: After 45 days from day of Enrollment	—

Countries

India

Contacts

Public ContactDr Avadhesh Kumar

Government PG Ayruveda college and Hospital Varanasi

dravadheshsaroj@gmail.com9455262663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026